SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-18-015591
Filing Date
2018-11-09
Accepted
2018-11-09 17:02:26
Documents
68
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 960157
2 ex10-1.htm EX-10.1 6744
3 ex10-1_001.jpg GRAPHIC 220276
4 ex10-1_002.jpg GRAPHIC 241255
5 ex10-1_003.jpg GRAPHIC 226761
6 ex10-1_004.jpg GRAPHIC 219208
7 ex10-1_005.jpg GRAPHIC 162083
8 ex10-1_006.jpg GRAPHIC 68544
9 ex31-1.htm EX-31.1 18126
10 ex31-2.htm EX-31.2 18443
11 ex32-1.htm EX-32.1 6418
  Complete submission text file 0001493152-18-015591.txt   5643117

Data Files

Seq Description Document Type Size
12 XBRL INSTANCE FILE mtnb-20180930.xml EX-101.INS 553917
13 XBRL SCHEMA FILE mtnb-20180930.xsd EX-101.SCH 49425
14 XBRL CALCULATION FILE mtnb-20180930_cal.xml EX-101.CAL 50766
15 XBRL DEFINITION FILE mtnb-20180930_def.xml EX-101.DEF 226182
16 XBRL LABEL FILE mtnb-20180930_lab.xml EX-101.LAB 357035
17 XBRL PRESENTATION FILE mtnb-20180930_pre.xml EX-101.PRE 278326
Mailing Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921
Business Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921 908-443-1860
Matinas BioPharma Holdings, Inc. (Filer) CIK: 0001582554 (see all company filings)

IRS No.: 463011414 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38022 | Film No.: 181173856
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1